Histogen Gets Nasdaq Listing Via Merger With Conatus

Conatus Pharmaceuticals has agreed to merge with another San Diego biotech, Histogen, it was announced Jan…

Take 1 minute to subscribe and you’ll get this story immediately, plus:

Already a subscriber? Sign in

52 weekly issues Subscriber-only digital content every business day, plus full access to SDBJ.com archives Book of Lists — the most comprehensive business resource in San Diego San Diego 500 — influential business leaders you need to know Yours for only $129

Read More Here...

Bookmark the permalink.

Comments are closed.